Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS

231.38 Jun 19, 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:287.94
Median Target:290.00
High Target:316.00
Low Target:225.00
No. of Brokers:17

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
May 16, 2013UBSInitiated Neutral
Feb 27, 2013BarclaysInitiated Overweight
Jan 9, 2012Robert W. BairdUpgradeNeutralOutperform
Apr 28, 2011RBC Capital MktsDowngradeOutperformSector Perform
Apr 26, 2011Boenning & ScattergoodInitiated Outperform
Apr 6, 2011MP AdvisorsUpgradeMarket PerformOutperform
Feb 23, 2011RBC Capital MktsUpgradeSector PerformOutperform
Feb 22, 2011Stifel NicolausInitiated Hold
Dec 15, 2010MP AdvisorsDowngradeOutperformMarket Perform
Oct 7, 2010Brean MurrayInitiated Buy

More Upgrades & Downgrades for REGN

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4333
Buy8776
Hold6877
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.